Osteotec Announces Exclusive UK and Ireland Distribution Agreement With SI-BONE
Osteotec Announces Exclusive UK and Ireland Distribution Agreement With SI-BONE
NEWBURY, England, May 16, 2024 /PRNewswire/ -- Osteotec, the market-leading manufacturer and distributor of medical devices, is pleased to announce a new partnership with SI-BONE to exclusively distribute the iFuse Implant System in the UK and Ireland.
英国纽伯里，2024年5月16日 /PRNewswire/ — 市场领先的医疗器械制造商和分销商Osteotec欣然宣布与SI-BONE建立新的合作伙伴关系，在英国和爱尔兰独家分销iFuse植入系统。
The strategic relationship is the newest addition to Osteotec's rapidly expanding offering to customers, which provides surgeons with innovative solutions.
这种战略关系是Osteotec快速扩展的客户服务的最新补充，为外科医生提供了创新的解决方案。
San Jose, California-based SI-BONE are at the forefront of advancing minimally invasive procedures for the sacroiliac (SI) joint. The iFuse Implant System is designed to provide immediate SI joint stabilisation and allow long-term fusion.
总部位于加利福尼亚州圣何塞的SI-BONE处于推进骶（SI）关节微创手术的最前沿。iFuse 植入系统旨在提供即时的 SI 关节稳定并允许长期融合。
To date, more than 55,000 minimally invasive surgical SI joint fusions have been performed with the iFuse Implant System by more than 2,400 surgeons worldwide.
迄今为止，全球已有2,400多名外科医生使用iFuse植入系统进行了超过55,000次微创手术SI关节融合术。
"We are pleased to be expanding our product offering to include the iFuse Implant System, and to be working with the UK's top spine surgeons to give them more options, expand our treatment offering and deliver better patient outcomes," said Dean Stockwell, Osteotec Sales & Marketing Director.
Osteotec销售与营销总监迪恩·斯托克韦尔表示：“我们很高兴能够扩大产品范围，将iFuse植入系统包括在内，并与英国顶级脊柱外科医生合作，为他们提供更多选择，扩大我们的治疗范围并提供更好的患者疗效。”
"Our customers have come to anticipate forward-thinking solutions from Osteotec, and this is just one more example of how we are increasing patient treatment options through investment in partnerships with manufacturers who share our values.
“我们的客户已经开始期待Osteotec的前瞻性解决方案，这只是我们如何通过投资与认同我们价值观的制造商建立合作伙伴关系来增加患者治疗选择的又一个例子。
"We look forward to working with the SI-BONE team to increase and support sales through our expertise, ensuring our customers enjoy the best possible experience, service, and support in the industry."
“我们期待与SI-BONE团队合作，通过我们的专业知识增加和支持销售，确保我们的客户享受业内最佳的体验、服务和支持。”
The SI joint is one of the most under-served, under-diagnosed, and under-treated areas in orthopaedics. The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.
SI 关节是骨科服务最差、诊断不足和治疗最差的部位之一。iFuse Implant System 适用于骶融合术，用于治疗包括骶关节功能障碍（直接由骶关节受损和退行性骶骨炎）引起的骶融合术。
It is anticipated that the agreement, which went into effect on April 1, 2024, will contribute to substantial increases in sales and revenue and accelerate growth.
预计该协议于2024年4月1日生效，将有助于销售和收入的大幅增长并加速增长。
"We are excited about working with Osteotec to expand our footprint in the UK and Ireland," said Neville Lorimer, SI-BONE Vice President, International.
SI-BONE国际副总裁内维尔·洛里默表示：“我们很高兴能与Osteotec合作扩大我们在英国和爱尔兰的足迹。”
"With the assistance of Osteotec's talented commercial team and extensive industry knowledge, we will be able to accelerate our strategic objective of providing superior patient outcomes in these markets."
“在Osteotec才华横溢的商业团队和丰富的行业知识的协助下，我们将能够加快实现我们在这些市场提供卓越患者疗效的战略目标。”
The two organisations look forward to combining their expertise and technologies to maximise marketing opportunities, increase productivity and improve healthcare outcomes.
这两个组织期待结合他们的专业知识和技术，最大限度地利用营销机会，提高生产力并改善医疗保健成果。
"This exclusive distribution agreement builds upon the shared values of both companies and will give our customers more focused support than ever before," said Dean Stockwell. "We are pleased to be collaborating with an organisation that values excellence as much as we do."
迪恩·斯托克韦尔说：“这项独家分销协议建立在两家公司的共同价值观基础上，将为我们的客户提供比以往任何时候都更加集中的支持。”“我们很高兴能与一个像我们一样重视卓越的组织合作。”
Editor's Notes
编者注
About Osteotec
关于 Osteotec
Osteotec is a manufacturer and distributor of medical devices headquarter in Newbury, UK, with offices in Dublin and Malmö. Established in 1993, Osteotec has been supplying into the NHS and private healthcare sectors for the past 31 years.
Osteotec是一家医疗器械的制造商和分销商，总部位于英国纽伯里，在都柏林和马尔默设有办事处。Osteotec成立于1993年，在过去的31年中一直为国民保健服务和私人医疗保健行业提供产品。
Osteotec manufactures and distributes the Osteotec Silicone Finger, ChiroKlip and the Concentric Bone Graft System and is the exclusive UK distributor for world-leading orthopaedic partners including SI-BONE, TriMed, Enovis and Mathys.
Osteotec生产和分销Osteotec硅胶手指、ChiroKlip和同心骨移植系统，并且是包括SI-BONE、TriMed、Enovis和Mathys在内的世界领先骨科合作伙伴的英国独家分销商。
Media Contact:
媒体联系人：
Ric Sumner
Head of Marketing
[email protected] | 020 3011 5574
For more information, visit –
里克·萨姆纳
营销主管
[电子邮件保护] | 020 3011 5574
欲了解更多信息，请访问—
About SI-BONE
关于 SI-BONE
SI-BONE is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 3,600 surgeons in performing a total of more than 95,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including two randomized controlled trials and over 125 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.
SI-BONE 是骶骨盆解剖结构肌肉骨骼疾病外科治疗技术的全球领导者。自2009年率先进行脊柱关节微创手术以来，SI-BONE已支持3,600多名外科医生进行了总共超过95,000例骶骨盆手术。大量独特的临床证据支持使用SI-BONE的技术，包括两项随机对照试验和超过125份同行评审出版物。SI-BONE利用其在微创SI关节融合术方面的领导地位，为邻近市场商业化了新的解决方案，包括成人畸形、脊柱固定和骨盆创伤。
For additional information on the company or the products including risks and benefits, please visit .
有关公司或产品的更多信息，包括风险和收益，请访问。
Logo:
徽标：
SOURCE Osteotec
来源 Osteotec